RAPIDONE - COCAINE TEST— 510(k) K990822

Name: FDA 510(k) clearance K990822
Creator: U.S. Food and Drug Administration
Published: 1999-07-15

Substantially Equivalent

American Bio Medica Corp.

FDA 510(k) clearance K990822 for RAPIDONE - COCAINE TEST, Substantially Equivalent on 1999-07-15. Applicant: American Bio Medica Corp.. Device class: 2.

Clearance details

Applicant: American Bio Medica Corp.
Product code: Code DIO
Device class: Class 2
Regulation: 21 CFR 862.3250
Advisory panel: Clinical Toxicology
Date received: 1999-03-11
Decision date: 1999-07-15
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Washington, DC, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DIO

view all

K213211 — Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test System2022-01-27
K211973 — DRI Cocaine Metabolite Assay2021-09-24
K191638 — Pointe Scientific Cocaine Metabolite Enzyme Immunoassay2020-03-12
K181499 — DRI Cocaine Metabolite Assay2018-07-06
K170293 — Emit II Plus Cocaine Metabolite Assay2017-10-25

More clearances from American Bio Medica Corp.

view all

K170222 — Rapid Tox Cup II2017-08-15
K073078 — RAPID TOX CUP2008-05-30
K060760 — RAPIDONE-BUPRENORPHINE TEST2006-08-07
K053422 — RAPIDONE-COCAINE-150 TEST2006-06-15
K053359 — RAPIDTOX2006-05-25

Data sourced from openFDA. This site is unofficial and independent of the FDA.